These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 23744056

  • 1. Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells.
    Korten S, Brunssen C, Poitz DM, Großklaus S, Brux M, Schnittler HJ, Strasser RH, Bornstein SR, Morawietz H, Goettsch W.
    Basic Res Cardiol; 2013 Jul; 108(4):362. PubMed ID: 23744056
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
    Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, Gessler M.
    Exp Cell Res; 2007 Jan 01; 313(1):1-9. PubMed ID: 17045587
    [Abstract] [Full Text] [Related]

  • 3. COUP-TFII is a major regulator of cell cycle and Notch signaling pathways.
    Chen X, Qin J, Cheng CM, Tsai MJ, Tsai SY.
    Mol Endocrinol; 2012 Aug 01; 26(8):1268-77. PubMed ID: 22734039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.
    You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY.
    Nature; 2005 May 05; 435(7038):98-104. PubMed ID: 15875024
    [Abstract] [Full Text] [Related]

  • 6. COUP-TFII is regulated by high glucose in endothelial cells.
    Brunssen C, Korten S, Brux M, Seifert S, Roesler J, Bornstein SR, Morawietz H, Goettsch W.
    Horm Metab Res; 2010 Feb 05; 42(2):81-7. PubMed ID: 19862665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.
    Kang J, Yoo J, Lee S, Tang W, Aguilar B, Ramu S, Choi I, Otu HH, Shin JW, Dotto GP, Koh CJ, Detmar M, Hong YK.
    Blood; 2010 Jul 08; 116(1):140-50. PubMed ID: 20351309
    [Abstract] [Full Text] [Related]

  • 10. COUP-TFII switches responses of venous endothelium to atherosclerotic factors through controlling the profile of various inherent genes expression.
    Wu X, Zou Y, Liang Y, Zhou Q, Gong H, Sun A, Yuan L, Wang K, Ge J.
    J Cell Biochem; 2011 Jan 08; 112(1):256-64. PubMed ID: 21069739
    [Abstract] [Full Text] [Related]

  • 11. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells.
    Hayashi H, Kume T.
    PLoS One; 2008 Jun 11; 3(6):e2401. PubMed ID: 18545664
    [Abstract] [Full Text] [Related]

  • 12. DNMT3A inhibits E2F1-induced arterial marker expression and impairs angiogenesis in human umbilical artery endothelial cells.
    Su K, Lin N, Xie S, Han Y, Yang Z, Zhang H, He H, Zhou SA, Ma W, Zhang T, Wang N.
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec 11; 52(11):1236-1246. PubMed ID: 33079978
    [Abstract] [Full Text] [Related]

  • 13. Arterial-venous specification during development.
    Swift MR, Weinstein BM.
    Circ Res; 2009 Mar 13; 104(5):576-88. PubMed ID: 19286613
    [Abstract] [Full Text] [Related]

  • 14. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.
    Kume T.
    Histol Histopathol; 2010 May 13; 25(5):637-46. PubMed ID: 20238301
    [Abstract] [Full Text] [Related]

  • 15. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells.
    Iso T, Maeno T, Oike Y, Yamazaki M, Doi H, Arai M, Kurabayashi M.
    Biochem Biophys Res Commun; 2006 Mar 17; 341(3):708-14. PubMed ID: 16430858
    [Abstract] [Full Text] [Related]

  • 16. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction.
    Yamazaki T, Yoshimatsu Y, Morishita Y, Miyazono K, Watabe T.
    Genes Cells; 2009 Mar 17; 14(3):425-34. PubMed ID: 19210544
    [Abstract] [Full Text] [Related]

  • 17. BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.
    Davis RB, Curtis CD, Griffin CT.
    Development; 2013 Mar 17; 140(6):1272-81. PubMed ID: 23406903
    [Abstract] [Full Text] [Related]

  • 18. Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation.
    Lanner F, Sohl M, Farnebo F.
    Arterioscler Thromb Vasc Biol; 2007 Mar 17; 27(3):487-93. PubMed ID: 17185616
    [Abstract] [Full Text] [Related]

  • 19. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
    Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY.
    Cancer Res; 2010 Nov 01; 70(21):8812-21. PubMed ID: 20978203
    [Abstract] [Full Text] [Related]

  • 20. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.
    Seo S, Fujita H, Nakano A, Kang M, Duarte A, Kume T.
    Dev Biol; 2006 Jun 15; 294(2):458-70. PubMed ID: 16678147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.